[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608725":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":26,"locations":36,"responsibleParty":62,"collaborators":20,"id":64,"slug":20,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":20,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":20,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":39,"whyStopped":20,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"GPN Vaccines","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Gamma -PN","EXPERIMENTAL","Intramuscular administration 500 mcg",[13],"Biological: Gamma-PN",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","Gamma-PN","Killed whole-cell pneumococcal vaccine",[9],null,[22],{"name":23,"affiliation":24,"role":25},"Eve Kennedy, PhD","GPN Vaccines Ltd","STUDY_DIRECTOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":20,"email":31},"Nerissa Lakhan, PhD","CONTACT","+61-432 161 783","nerissa@gpnvaccines.com",{"name":33,"role":29,"phone":34,"phoneExt":20,"email":35},"Paul E Rolan, MD","+61-405 670 420","paul@gpnvaccines.com",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"University of Adelaide Clinical Research Facility","RECRUITING","Adelaide","South Australia","5000","Australia",{"type":45,"coordinates":46},"Point",[47,48],138.59863,-34.92866,{"lat":48,"lon":47},[51,55,59],{"name":52,"role":29,"phone":53,"phoneExt":20,"email":54},"Kirstee Smith","+61-481-589 855","kirstee.smith@adelaide.edu.au",{"name":56,"role":29,"phone":20,"phoneExt":57,"email":58},"Sepehr Shakib, MD PhD","+61-411-100 27","sepehr.shakib@adelaide.edu.au",{"name":60,"role":61,"phone":20,"phoneExt":20,"email":20},"Tom Polasek, MD PhD","PRINCIPAL_INVESTIGATOR",{"type":63,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100608725",false,"NCT07205289","Serum Collection Study for Assay Development","A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation","Inclusion Criteria:\n\n* good general health\n\nExclusion Criteria:\n\n* no previous pneumococcal vaccine",true,"ALL","18 Years","69 Years",{"count":75,"type":76},12,"ESTIMATED","INTERVENTIONAL",[79],"PHASE1","The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation",[82,83],"Pneumococcal Disease, Invasive","Pneumococcal Disease",[85],"Vaccination pneumococcal","2025-09-25",{"date":88,"type":89},"2025-10-03","ACTUAL",{"date":91,"type":76},"2025-10",{"date":93,"type":76},"2026-06",{"name":5,"class":6},1]